oral GLP-1

Wegovy (semaglutide) injectable
May 6, 2025

Novo Nordisk seeks FDA approval for Wegovy weight loss pill

If the administration signs off on the application, the company’s experimental once-daily version will become the first oral GLP-1 for weight loss.